EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.
Once-weekly insulins offer a way to simplify therapy and reduce the treatment burden for people with type 2 diabetes, and also have potential for individuals with type 1 diabetes.
Intermittently scanning CGM detected hypoglycemia in a woman previously diagnosed with schizophrenia and treated with antipsychotic medication. Insulinoma was diagnosed and resected, resolving her neuropsychiatric symptoms.
Children with type 1 diabetes who are admitted to hospital can continue to receive their insulin via a home-based system while being treated as inpatients.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.
Intermittently scanning CGM detected hypoglycemia in a woman previously diagnosed with schizophrenia and treated with antipsychotic medication. Insulinoma was diagnosed and resected, resolving her neuropsychiatric symptoms.
This case indicates that capillary blood glucose monitoring should be used alongside intermittently scanned CGM when pregnancy is complicated by type 1 diabetes and CKD.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
Diabetes mellitus (DM) and premenstrual syndrome (PMS) are global health challenges. Both disorders are often linked to a range of physical and psychological symptoms that significantly impact the quality of life of many women. Yet, the exact …
In the late 90s, sodium-glucose cotransporter type 2 (SGLT2) inhibitors were developed as non-insulin-dependent antidiabetic drugs, and were eventually approved by the Food and Drug Administration and the European Medicines Agency between 2012 and …
Early initiation of intensive insulin therapy has been demonstrated to be effective in controlling glycemia and possibly preserving beta-cell function. Innovations in insulin formulations and delivery systems continue. However, we have seen an …
Diabetes mellitus (DM) is a metabolic disorder characterized by elevated plasma glucose that impacts multiple organ systems. It encompasses various subtypes such as type 1 DM (T1DM), type 2 DM (T2DM), maturity-onset diabetes of the young (MODY) …
An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.
The study was carried out to determine the psychosocial outcomes of advanced hybrid closed-loop (AHCL) systems in children and adolescents with type 1 diabetes (T1D). Single-center and cohort study with a duration 6 months consisted of 60 children …
Multiple daily injection insulin regimen (MDI), also referred to as intensive insulin therapy (IIT), represents the most complex type of insulin regimen used in the management of people with type 2 diabetes (PwT2D). Correspondingly, MDI regimen …
Insulin therapy is a necessary step in achieving optimal glycemic targets in type 1 diabetes (T1DM), but also in most advanced patients with type 2 diabetes (T2DM) when oral antidiabetic agents and non-insulin injectable treatments have failed to …
The International Diabetes Federation (IDF) Atlas reported that in 2021, 537 million people had diabetes globally; of these, type 2 diabetes is estimated to account for over 90% of cases [ 1 , 2 ]. This number is predicted to increase by 46% to 783 …